Additionally, they indicated that stool-based DNA methylation methods could be developed for the early identification of cancer and dysplasia in IBD patients using the methylation of APC1A, APC2, SFRP1, and SFRP2.5 The gene discussed is SFRP2; the disease is inflammatory bowel disease.